Genistein in Sanfilippo disease: A randomized controlled crossover trial-Reference-Cited by-同舟云学术

Genistein in Sanfilippo disease: A randomized controlled crossover trial

Published:2012-01 Issue:1 Volume:71 Page:110-120
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

de Ruijter Jessica,Valstar Marlies J.,Narajczyk Magdalena,Wegrzyn Grzegorz,Kulik Wim,IJlst Lodewijk,Wagemans Tom,van der Wal Willem M.,Wijburg Frits A.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference33 articles.

1. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C);van de Kamp;Clin Genet,1981

2. Incidence of inborn errors of metabolism in British Columbia, 1969-1996;Applegarth;Pediatrics,2000

3. Sanfilippo syndrome: a mini-review;Valstar;J Inherit Metab Dis,2008

4. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome);Meyer;Hum Mutat,2008

5. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype;Valstar;J Inherit Metab Dis,2010

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond;BioDrugs;2024-08-23

2. Inhibitors of dermatan sulfate epimerase 1 decreased accumulation of glycosaminoglycans in mucopolysaccharidosis type I fibroblasts;Glycobiology;2024-04-24

3. Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model;Cell Biochemistry and Function;2024-02-08

4. Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation;Journal of Inherited Metabolic Disease;2024-01-18

5. Safety and Efficacy of Genistein in Sanfilippo Syndrome - A Systematic Review;Current Drug Therapy;2023-08